Works matching IS 10837159 AND DT 2021 AND VI 26 AND IP 1

Results: 37
    1
    2
    3
    4
    5

    In Reply.

    Published in:
    Oncologist, 2021, v. 26, n. 1, p. e192, doi. 10.1002/onco.13589
    By:
    • Gubbi, Sriram;
    • Cordes, Lisa M.;
    • Klubo‐Gwiezdzinska, Joanna;
    • Madan, Ravi A.;
    • Nieman, Lynnette K.;
    • Gulley, James L.;
    • Del Rivero, Jaydira
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12

    The Impact of the COVID‐19 Pandemic on Surgical Management of Breast Cancer: Global Trends and Future Perspectives.

    Published in:
    Oncologist, 2021, v. 26, n. 1, p. e66, doi. 10.1002/onco.13560
    By:
    • Rocco, Nicola;
    • Montagna, Giacomo;
    • Micco, Rosa;
    • Benson, John;
    • Criscitiello, Carmen;
    • Chen, Li;
    • Di Pace, Bruno;
    • Esgueva Colmenarejo, Antonio Jesus;
    • Harder, Yves;
    • Karakatsanis, Andreas;
    • Maglia, Anna;
    • Mele, Marco;
    • Nafissi, Nahid;
    • Ferreira, Pedro Santos;
    • Taher, Wafa;
    • Tejerina, Antonio;
    • Vinci, Alessio;
    • Nava, Maurizio;
    • Catanuto, Giuseppe
    Publication type:
    Article
    13

    FDA Approval Summary: Olaparib Monotherapy or in Combination with Bevacizumab for the Maintenance Treatment of Patients with Advanced Ovarian Cancer.

    Published in:
    Oncologist, 2021, v. 26, n. 1, p. e164, doi. 10.1002/onco.13551
    By:
    • Arora, Shaily;
    • Balasubramaniam, Sanjeeve;
    • Zhang, Hui;
    • Berman, Tara;
    • Narayan, Preeti;
    • Suzman, Daniel;
    • Bloomquist, Erik;
    • Tang, Shenghui;
    • Gong, Yutao;
    • Sridhara, Rajeshwari;
    • Turcu, Francisca Reyes;
    • Chatterjee, Deb;
    • Saritas‐Yildirim, Banu;
    • Ghosh, Soma;
    • Philip, Reena;
    • Pathak, Anand;
    • Gao, Jennifer J.;
    • Amiri‐Kordestani, Laleh;
    • Pazdur, Richard;
    • Beaver, Julia A.
    Publication type:
    Article
    14
    15
    16
    17
    18

    Phase I/II Study of Cisplatin plus Nab‐Paclitaxel with Concurrent Thoracic Radiotherapy for Patients with Locally Advanced Non‐Small Cell Lung Cancer.

    Published in:
    Oncologist, 2021, v. 26, n. 1, p. 19, doi. 10.1002/ONCO.13524
    By:
    • Hayashi, Hidetoshi;
    • Ogura, Masakazu;
    • Niwa, Takashi;
    • Yokoyama, Toshihide;
    • Tanizaki, Junko;
    • Ozaki, Tomohiro;
    • Yoshioka, Hiroshige;
    • Kurata, Takayasu;
    • Tamura, Yosuke;
    • Fujisaka, Yasuhito;
    • Tanaka, Kaoru;
    • Hasegawa, Yoshikazu;
    • Kudo, Keita;
    • Chiba, Yasutaka;
    • Nakagawa, Kazuhiko
    Publication type:
    Article
    19

    Phase II Study of Panitumumab Monotherapy in Chemotherapy‐Naïve Frail or Elderly Patients with Unresectable RAS Wild‐Type Colorectal Cancer: OGSG 1602.

    Published in:
    Oncologist, 2021, v. 26, n. 1, p. 17, doi. 10.1002/ONCO.13523
    By:
    • Terazawa, Tetsuji;
    • Kato, Takeshi;
    • Goto, Masahiro;
    • Ohta, Katsuya;
    • Noura, Shingo;
    • Satake, Hironaga;
    • Kagawa, Yoshinori;
    • Kawakami, Hisato;
    • Hasegawa, Hiroko;
    • Yanagihara, Kazuhiro;
    • Shingai, Tatsushi;
    • Nakata, Ken;
    • Kotaka, Masahito;
    • Hiraki, Masayuki;
    • Konishi, Ken;
    • Nakae, Shiro;
    • Sakai, Daisuke;
    • Kurokawa, Yukinori;
    • Shimokawa, Toshio;
    • Satoh, Taroh
    Publication type:
    Article
    20
    21

    Targetable BRAF and RAF1 Alterations in Advanced Pediatric Cancers.

    Published in:
    Oncologist, 2021, v. 26, n. 1, p. e153, doi. 10.1002/ONCO.13519
    By:
    • Rankin, Andrew;
    • Johnson, Adrienne;
    • Roos, Alison;
    • Kannan, Geoffrey;
    • Knipstein, Jeffrey;
    • Britt, Nicholas;
    • Rosenzweig, Mark;
    • Haberberger, James;
    • Pavlick, Dean;
    • Severson, Eric;
    • Vergilio, Jo‐Anne;
    • Squillace, Rachel;
    • Erlich, Rachel;
    • Sathyan, Pratheesh;
    • Cramer, Stuart;
    • Kram, David;
    • Ross, Jeffrey;
    • Miller, Vince;
    • Reddy, Prasanth;
    • Alexander, Brian
    Publication type:
    Article
    22
    23
    24
    25
    26
    27

    Modified ypTNM Staging Classification for Gastric Cancer after Neoadjuvant Therapy: A Multi‐Institutional Study.

    Published in:
    Oncologist, 2021, v. 26, n. 1, p. e99, doi. 10.1634/theoncologist.2020-0022
    By:
    • Zhong, Qing;
    • Chen, Qi‐Yue;
    • Parisi, Amilcare;
    • Ma, Yu‐Bin;
    • Lin, Guang‐Tan;
    • Desiderio, Jacopo;
    • Yan, Su;
    • Xie, Jian‐Wei;
    • Wang, Jia‐Bin;
    • Hou, Jun‐Fang;
    • Lin, Jian‐Xian;
    • Lu, Jun;
    • Cao, Long‐Long;
    • Lin, Mi;
    • Tu, Ru‐Hong;
    • Huang, Ze‐Ning;
    • Lin, Ju‐Li;
    • Liu, Zhi‐Yu;
    • Que, Si‐Jin;
    • Li, Ping
    Publication type:
    Article
    28
    29

    Cancer and Risk of COVID‐19 Through a General Community Survey.

    Published in:
    Oncologist, 2021, v. 26, n. 1, p. 1, doi. 10.1634/theoncologist.2020-0572
    By:
    • Lee, Karla A.;
    • Ma, Wenjie;
    • Sikavi, Daniel R.;
    • Drew, David A.;
    • Nguyen, Long H.;
    • Bowyer, Ruth C. E.;
    • Cardoso, M. Jorge;
    • Fall, Tove;
    • Freidin, Maxim B.;
    • Gomez, Maria;
    • Graham, Mark;
    • Guo, Chuan‐Guo;
    • Joshi, Amit D.;
    • Kwon, Sohee;
    • Lo, Chun‐Han;
    • Lochlainn, Mary Ni;
    • Menni, Cristina;
    • Murray, Benjamin;
    • Mehta, Raaj;
    • Song, Mingyang
    Publication type:
    Article
    30

    Therapeutic Potential of Afatinib in NRG1 Fusion‐Driven Solid Tumors: A Case Series.

    Published in:
    Oncologist, 2021, v. 26, n. 1, p. 7, doi. 10.1634/theoncologist.2020-0379
    By:
    • Cadranel, Jacques;
    • Liu, Stephen V.;
    • Duruisseaux, Michaël;
    • Branden, Eva;
    • Goto, Yasushi;
    • Weinberg, Benjamin A.;
    • Heining, Christoph;
    • Schlenk, Richard F.;
    • Cheema, Parneet;
    • Jones, Martin R.;
    • Drilon, Alexander;
    • Trombetta, Domenico;
    • Muscarella, Lucia Anna;
    • Tolba, Khaled;
    • Gounant, Valerie;
    • Cseh, Agnieszka;
    • Solca, Flavio;
    • Laskin, Janessa J.;
    • Renouf, Daniel J.
    Publication type:
    Article
    31
    32

    Modified FOLFOXIRI With or Without Cetuximab as Conversion Therapy in Patients with RAS/BRAF Wild‐Type Unresectable Liver Metastases Colorectal Cancer: The FOCULM Multicenter Phase II Trial.

    Published in:
    Oncologist, 2021, v. 26, n. 1, p. e90, doi. 10.1634/theoncologist.2020-0563
    By:
    • Hu, Huabin;
    • Wang, Kun;
    • Huang, Meijin;
    • Kang, Liang;
    • Wang, Wei;
    • Wang, Hui;
    • Qiu, Meng;
    • Lin, Rongbo;
    • Zhang, Haibo;
    • Lan, Ping;
    • Wu, Xiaojian;
    • Liu, Guangjian;
    • Wan, Yunle;
    • Liu, Ming;
    • Zhou, Zhiyang;
    • Huang, Yan;
    • Li, Fangqian;
    • Zhang, Jianwei;
    • Cai, Yue;
    • Ma, Tenghui
    Publication type:
    Article
    33

    Metoclopramide, Dexamethasone, or Palonosetron for Prevention of Delayed Chemotherapy‐Induced Nausea and Vomiting After Moderately Emetogenic Chemotherapy (MEDEA): A Randomized, Phase III, Noninferiority Trial.

    Published in:
    Oncologist, 2021, v. 26, n. 1, p. e173, doi. 10.1634/theoncologist.2020-0305
    By:
    • Vorst, Maurice J.D.L.;
    • Toffoli, Elisa C.;
    • Beusink, Marlien;
    • Linde, Myra E.;
    • Voorthuizen, Theo;
    • Brouwer, Saskia;
    • Zweeden, Annette A.;
    • Vrijaldenhoven, Suzan;
    • Berends, Johan C.;
    • Berkhof, Johannes;
    • Verheul, Henk M.W.
    Publication type:
    Article
    34
    35
    36
    37

    Going Back.

    Published in:
    Oncologist, 2021, v. 26, n. 1, p. 86, doi. 10.1634/theoncologist.2020-0628
    By:
    • Leichman, Lawrence
    Publication type:
    Article